| Application no. and date | 19162585.4 (espacenet) (Federated) (European Patent Register), 20140807 | | Patent/reg. no. and date | DK/EP 3536339, 20211006 | | Publication date | 20190911 | | Priority no. and date | US 201361864950 P, 20130812 | | EP pub. no. and date |
EP 3536339 20190911 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | | Applicant ref. no. | 1592100 | | Inventor | ROSKOS, Lorin, MedImmune LLC
One MedImmune Way
Gaithersburg, Maryland 20878, US,
WARD, Christine, Medimmune LLC
One Medimmune Way
Gaithersburg, Maryland 20878, US,
WANG, Bing, Medimmune LLC
One Medimmune Way
Gaithersburg, Maryland 20878, US,
RAIBLE, Donald, 317 Lenape Drive
Berwyn, Pennsylvania 19312, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 11/06 (2006.01) , G01N 33/48 (2006.01) | | Title | FREMGANGSMÅDE TIL FORBEDRING AF ASTMASYMPTOMER VED ANVENDELSE AF BENRALIZUMAB | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
